Your browser doesn't support javascript.
loading
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.
Kimball, Alexa B; Okun, Martin M; Williams, David A; Gottlieb, Alice B; Papp, Kim A; Zouboulis, Christos C; Armstrong, April W; Kerdel, Francisco; Gold, Michael H; Forman, Seth B; Korman, Neil J; Giamarellos-Bourboulis, Evangelos J; Crowley, Jeffrey J; Lynde, Charles; Reguiai, Ziad; Prens, Errol-Prospero; Alwawi, Eihab; Mostafa, Nael M; Pinsky, Brett; Sundaram, Murali; Gu, Yihua; Carlson, Dawn M; Jemec, Gregor B E.
Afiliação
  • Kimball AB; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Okun MM; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Williams DA; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Gottlieb AB; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Papp KA; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Zouboulis CC; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Armstrong AW; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Kerdel F; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Gold MH; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Forman SB; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Korman NJ; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Giamarellos-Bourboulis EJ; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Crowley JJ; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Lynde C; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Reguiai Z; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Prens EP; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Alwawi E; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Mostafa NM; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Pinsky B; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Sundaram M; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Gu Y; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Carlson DM; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
  • Jemec GB; From Harvard Medical School and Massachusetts General Hospital (A.B.K.) and Tufts Medical Center (A.B.G.) - all in Boston; AbbVie, North Chicago, IL (M.M.O., D.A.W., E.A., N.M.M., B.P., M.S., Y.G., D.M.C.); Probity Medical Research and K Papp Clinical Research, Waterloo, ON (K.A.P.), and the Lynde C
N Engl J Med ; 375(5): 422-34, 2016 Aug 04.
Article em En | MEDLINE | ID: mdl-27518661
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Necrose Tumoral alfa / Hidradenite Supurativa / Adalimumab / Anti-Inflamatórios Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: N Engl J Med Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Necrose Tumoral alfa / Hidradenite Supurativa / Adalimumab / Anti-Inflamatórios Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: N Engl J Med Ano de publicação: 2016 Tipo de documento: Article